Flavin Mononucleotide

This is a type of vitamin called riboflavin. It's important for energy production in your body. It's found in many foods and is also used in some medicines.

Brand names:FMN
Medication

What people taking Flavin Mononucleotide report

Every report comes from a Lived member, sent anonymously.

NameHow it went

No reports yet

Add what worked for you with the search bar below

About Flavin Mononucleotide

What It's For

Flavin mononucleotide (FMN), also called riboflavin 5'-phosphate, is the form of riboflavin (vitamin B2) that the body's cells actually use. As a prescription medicine, its main use is as an eye drop in corneal cross-linking, a procedure that strengthens a weakened cornea, the clear dome at the front of the eye. The condition it treats most often is keratoconus, in which the cornea thins and bulges into a cone shape, making vision increasingly blurry and distorted. Two brands are approved in the US. Photrexa and Photrexa Viscous are used in the standard "epithelium-off" procedure for progressive keratoconus and for corneal ectasia, a similar bulging that can develop after laser vision surgery such as LASIK. Epioxa and Epioxa HD are used in a newer "epithelium-on" procedure for keratoconus in people 13 and older. Each brand works only with its own ultraviolet light system, so the choice of drops comes with the choice of procedure. Riboflavin 5'-phosphate also appears as the vitamin B2 ingredient in some prescription multivitamins, including intravenous vitamins for people fed through a vein and children's vitamin drops with fluoride. In those products it simply supplies vitamin B2. Ordinary vitamin B2 supplements are a separate topic and are not covered here.

How It Works

Inside the body, FMN helps enzymes carry out the chemical reactions that turn food into energy. Its role in cross-linking is different and depends on light. The cornea gets its strength from fibers of collagen, a structural protein. In keratoconus those fibers are too weak to hold the cornea's normal curve. During cross-linking, the drops soak into the cornea and then the eye is exposed to a measured dose of ultraviolet A (UVA) light. The riboflavin absorbs that light and produces a reactive form of oxygen that forms new bonds between neighboring collagen fibers. The cornea becomes stiffer, which helps keep it from bulging further. Cross-linking is meant to stabilize the cornea, not to restore its normal shape. It does not correct vision on its own.

Dosage & Administration

The drops are not something you use at home. An eye doctor applies them during a single office procedure, after numbing drops, with the eye held open. In the epithelium-off procedure (Photrexa), the doctor first removes the thin surface layer of the cornea, called the epithelium, so the riboflavin can soak in. Drops are given every couple of minutes for about 30 minutes, then the eye is treated with UVA light for another 30 minutes while drops continue. The cornea must be thick enough before the light is used (at least 400 microns, or 0.4 mm), and the doctor measures it and may add a thinner riboflavin drop to swell a cornea that is too thin. A bandage contact lens usually covers the eye while it heals. In the epithelium-on procedure (Epioxa), the surface layer stays in place. After a shorter series of drops, the person wears goggles that deliver extra oxygen while the light is pulsed for about 11 minutes. The cornea must be at least 325 microns thick, and a bandage contact lens is placed afterward. For the first five days after epithelium-off treatment, avoid rubbing the eye. If the bandage lens falls out or moves out of place, do not put it back yourself; call the eye doctor right away.

Side Effects

Most side effects come from the procedure rather than the riboflavin itself. After epithelium-off treatment, the first few days are often uncomfortable while the surface layer grows back: eye pain, a gritty feeling, watering, sensitivity to light and blurred vision are common. Sunglasses help with light sensitivity. A faint cloudiness of the cornea, called haze, is very common; it usually fades but can take up to a year to clear. A small number of people still have some haze or scarring at one year. With the epithelium-on procedure, eye redness is the most common effect, and haze, light sensitivity, pain and irritation also occur. The most important complication is infection or a corneal ulcer while the surface is healing, which can threaten vision. Severe pain in the treated eye or a sudden drop in vision needs an immediate call to the eye doctor.

Interactions & Warnings

Riboflavin eye drops have no known drug interactions that affect the procedure, but the eye doctor should know about other eye conditions, previous eye surgery and any eye drops you use. Cross-linking should not be done during pregnancy, because its effects on a developing baby have not been studied. Mention pregnancy or plans for pregnancy before scheduling. There is no information on the drops in breast milk, so breastfeeding is a point to discuss with the eye doctor. For the epithelium-on procedure (Epioxa), there are some extra limits. It is not used in an eye whose natural lens has been removed without an artificial lens, or in an eye with an artificial lens that does not block ultraviolet light. It is also not used in people allergic to benzalkonium chloride, a preservative in the drops. Anyone who has had herpes infection of the cornea should say so, because cross-linking can reactivate it. The Photrexa procedure is not established as safe and effective in children under 14. Epioxa is approved from age 13.

What to Expect

Recovery after the epithelium-off procedure takes the most patience. Discomfort is usually worst in the first days, vision is often blurry for weeks, and some effects such as haze, dryness and light sensitivity can take months to settle. The eye doctor checks healing closely in the first days and weeks, then at intervals over the following year. Epithelium-on treatment is designed to be easier on the surface of the eye. The goal is to stop keratoconus from getting worse. In the US studies of the epithelium-off procedure, treated corneas flattened slightly over a year while untreated ones kept steepening, a difference of about 2 diopters in curvature. With epithelium-on treatment, the average difference was smaller, about 1 diopter, and in one study people 29 and older did not show improvement at six months. Cross-linking does not always halt the disease: in pooled studies of children, roughly 1 in 10 treated eyes still progressed, which is why follow-up measurements continue after the eye has healed. Because cross-linking stabilizes rather than reshapes the cornea, most people still need glasses or contact lenses, often specialty contacts, to see clearly. Avoiding eye rubbing remains important long term, since rubbing can damage a thin cornea.

Questions to Ask Your Doctor

  1. 1.Is my keratoconus actually getting worse, and what measurements show that?
  2. 2.Would the epithelium-off or epithelium-on procedure suit my eye better, and why?
  3. 3.How long will recovery take, and when can I return to work, driving and wearing contact lenses?
  4. 4.How will we know whether the treatment has worked, and what happens if my cornea keeps changing?
  5. 5.Will I still need glasses or special contact lenses afterward, and are other treatments worth considering?

Last reviewed • Oct 2026

Educational content, not medical advice.